Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (64), Hormone Deficiencies
...CenterWatch: New Medical Therapies in Disease Category (64), Hormone Deficiencies Hormone Deficiencies Patient Medical Areas • Endocrinology • Pediatrics/Neonatology January 15, 2007 QuatRx announced positive results from ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (269), Growth Hormone Deficiencies/Abnormalities
...CenterWatch: New Medical Therapies in Disease Category (269), Growth Hormone Deficiencies/Abnormalities Growth Hormone Deficiencies/Abnormalities Patient Medical Areas • Endocrinology • Pediatrics/Neonatology October 3, 2005 Altus Pharmaceuticals issued positive ...
View Page

3.  Study Posting (713) Trial #69069, Polycystic Ovarian Syndrome, Charlottesville, VA
...Study Posting (713) Trial #69069, Polycystic Ovarian Syndrome, Charlottesville, VA Trial Information Reproductive Hormone Studies in Adult Women. IRB-HSR# 10842/ JCM018 This study s goal is to examine how dihydrotestosterone (a male hormone ) helps control the secretion of gonadotropin-releasing hormone (GnRH). (GnRH controls the secretion of hormones ...
View Page

4.  Study Posting (713) Trial #152590, Reproductive Health, Charlottesville, VA
...Study Posting (713) Trial #152590, Reproductive Health, Charlottesville, VA Trial Information Reproductive Hormone study in Adult Women. IRB-HSR# 14067 / CRM004 The goal of this study is to determine whether testosterone (a male hormone ) helps control the secretion of gonadotropin-releasing hormone (GnRH) while awake and while asleep. (GnRH ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (171), Hormone Replacement Therapy: Menopause
...CenterWatch: New Medical Therapies in Disease Category (171), Hormone Replacement Therapy: Menopause Hormone Replacement Therapy: Menopause Patient Medical Areas • Endocrinology • Obstetrics/Gynecology July 15, 2002 The National Institutes ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (556), Metabolic Syndrome
...LAB International has announced positive results of a phase I/II trial of their Growth Hormone Releasing Hormone (GHRH) analog , being developed as an inhalable treatment for growth hormone (GH) deficiency caused by ...
View Page

7.  Newly Approved Drug Therapies (698) Femara (letrozole), Novartis,
...conference presentations. Drug Name: Femara (letrozole) Company: Novartis Approval Status: Approved January 2001 Treatment Area: Hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer General Information Femara has been approved for ...
View Page

8.  Study Posting (1918) Trial #160124, Breast Cancer, Savannah, GA
...Study Posting (1918) Trial #160124, Breast Cancer, Savannah, GA Trial Information Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node ...
...TAILORx Trial) ECOG PACCT-1 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy may fight breast cancer by blocking the use of estrogen by the tumor cells ...
View Page

9.  Study Posting (4912) Trial #137325, Breast Cancer, Paramus, NJ
...Study Posting (4912) Trial #137325, Breast Cancer, Paramus, NJ Trial Information Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node ...
...Negative Breast Cancer (The TAILORx Trial) Estrogen can cause the growth of breast cancer cells. Hormone therapy may fight breast cancer by blocking the use of estrogen by the tumor cells ...
View Page

10.  Study Posting (1918) Trial #159850, Prostate Cancer, Savannah, GA
...GA Trial Information Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer CCCWFU 97405 RATIONALE : Soy protein/isoflavones and venlafaxine may help relieve hot flashes in patients receiving hormone therapy for prostate cancer. It is not yet known whether soy protein/isoflavones are more ...
View Page

11.  Study Posting (1918) Trial #159849, Hot Flash, Savannah, GA
...GA Trial Information Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer CCCWFU 97405 RATIONALE : Soy protein/isoflavones and venlafaxine may help relieve hot flashes in patients receiving hormone therapy for prostate cancer. It is not yet known whether soy protein/isoflavones are more ...
View Page

12.  Study Posting (256) Trial #33762, Hormone Replacement Therapy: Menopause, Endwell, NY
...Study Posting (256) Trial #33762, Hormone Replacement Therapy: Menopause, Endwell, NY Trial Information Regional Clinical Research, Inc. is looking for healthy ...
...women to participate in a research study testing the safety and effectiveness of an investigational hormone replacement medication. If you qualify you will receive: • Study-related medical care, mammograms and study ...
View Page

13.  Study Posting (1570) Trial #156575, Growth Hormone Deficiencies/Abnormalities, Morristown, NJ
...Study Posting (1570) Trial #156575, Growth Hormone Deficiencies/Abnormalities, Morristown, NJ Trial Information American Norditropin Studies - Registry of Growth Hormone (GH) Patients (ANSWERProg) The Norditropin National Registry is a post-marketing registry of patients using ...
View Page

14.  Study Posting (713) Trial #69068, Women's Health, Charlottesville, VA
...Study Posting (713) Trial #69068, Women's Health, Charlottesville, VA Trial Information Adolescent Hormone Study Girls ages 8 to 18, who are not taking hormonal medications, are needed for studies of reproductive hormone changes during adolescence. Some studies involve a single blood sample or an overnight admission in ...
View Page

15.  Study Posting (713) Trial #47655, Polycystic Ovarian Syndrome, Charlottesville, VA
...Study Posting (713) Trial #47655, Polycystic Ovarian Syndrome, Charlottesville, VA Trial Information Adolescent Hormone Study Girls ages 8 to 18, who are not taking hormonal medications, are needed for studies of reproductive hormone changes during adolescence. Some studies involve a single blood sample or an overnight admission in ...
View Page

16.  Study Posting (713) Trial #47599, Polycystic Ovarian Syndrome, Charlottesville, VA
...Study Posting (713) Trial #47599, Polycystic Ovarian Syndrome, Charlottesville, VA Trial Information Adolescent Hormone Study Girls ages 8 to 18, who are not taking hormonal medications, are needed for studies of reproductive hormone changes during adolescence. Some studies involve a single blood sample or an overnight admission in ...
View Page

17.  Study Posting (2348) Trial #55131, Prostate Cancer, New York, NY
...Brachytherapy and Three-Dimensional Conformal Radiotherapy Standard treatment for prostate cancer includes radiation therapy and hormone therapy. Radiation therapy uses high energy x-rays to damage the cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens(male hormones that make ...
View Page

18.  Study Posting (713) Trial #17057, Polycystic Ovarian Syndrome, Charlottesville, Va
...studying how metformin, a medication that reduces insulin levels in blood, affects secretion of luteinizing hormone (LH). LH is a hormone that is elevated in women with PCOS, and stimulates the ovary to produce too much ...
View Page

19.  Study Posting (799) Trial #158924, Growth Hormone Deficiencies/Abnormalities, Boston, MA
...Study Posting (799) Trial #158924, Growth Hormone Deficiencies/Abnormalities, Boston, MA Trial Information Physiologic Effects of Long-Term GHRH 1-44 in ...
...Obesity OVERWEIGHT WITH A LARGE WAIST? Participate in a research study of a new growth hormone releasing factor on reducing abdominal fat. •18-55 yrs. old FEMALES (with reg. periods, not ...
View Page

20.  Study Posting (1918) Trial #159183, Breast Cancer, Savannah, GA
...Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer CTSU/IBCSG 24-02 RATIONALE: Estrogen can stimulate the growth of breast tumor cells. Ovarian function suppression combined with hormone therapy using tamoxifen or exemestane may fight breast cancer by reducing the production of estrogen ...
View Page